Science Explorer Back to mapMap
Discussion
Researcher · Simulations Plus (United States) · United States

Sébastien Bihorel

Sébastien Bihorel publishes mostly in Oncology, Hematology and Molecular Biology, on topics such as Chronic Myeloid Leukemia Treatments, Lipid metabolism and disorders and Lipoproteins and Cardiovascular Health.

ORCID 0000-0002-2326-3335 OpenAlex
World rank
#2,940,685
of 7,710,434 ranked researchers
Rank in United States
#847,026
of 1,627,098
Works
25
Citations
435
Citations per work
17.4
h-index
10
i10-index 10Top 59% in Oncology
Sébastien Bihorel

What does Sébastien Bihorel research?

Sébastien Bihorel's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).

Everything else: 12 works · 47.7% of their workHealth Sciences: 10 works · 38.8% of their workMedicine: 10 works · 38.8% of their workHematology: 3 works · 10.4% of their workOncology: 3 works · 10.4% of their workCardiology and Cardiovascular Medicine: 2 works · 9.0% of their workSurgery: 2 works · 9.0% of their workLife Sciences: 3 works · 13.5% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 9.0% of their workMolecular Biology: 2 works · 9.0% of their workImmunology and Microbiology: 1 works · 4.5% of their workImmunology: 1 works · 4.5% of their workTHEIR WORKSébastien Bihorel25works
Life Sciences14%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1247.7%
    1. Medicine1038.8%
    1. Biochemistry, Genetics and Molecular Biology29.0%
    2. Immunology and Microbiology14.5%
  1. 1Oncology10% of their works
  2. 2Hematology10% of their works
  3. 3Molecular Biology9% of their works
  4. 4Cardiology and Cardiovascular Medicine9% of their works
  5. 5Surgery9% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Sébastien Bihorel's research?

The keywords of their largest research topics: Clinical Trials, BCR-ABL, Imatinib, ANGPTL3, Cholesterol-lowering, Lipoprotein Lipase, Statins and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Clinical Trials62 topics
  2. BCR-ABL51 topic
  3. Imatinib51 topic
  4. ANGPTL341 topic
  5. Cholesterol-lowering41 topic
  6. Lipoprotein Lipase41 topic
  7. Statins41 topic
  8. AML21 topic
  9. ATP-dependent Transporters21 topic
  10. Acute Myeloid Leukemia21 topic
  11. Epilepsy21 topic
  12. Multidrug Resistance21 topic
  13. Off-Label Drug Use21 topic
  14. Pediatric Pharmacokinetics21 topic
  15. Pulmonary Hypertension21 topic
  16. Right Heart Assessment21 topic
  17. Seizures21 topic

Where does Sébastien Bihorel work?

Sébastien Bihorel's main affiliation in the publication record is Simulations Plus (United States), United States.

How many publications and citations does Sébastien Bihorel have?

OpenAlex counts 25 works and 435 citations for Sébastien Bihorel, an h-index of 10, ranking #2,940,685 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sébastien Bihorel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.